Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients

Abstract Background Toll-like (TLRs) play a crucial role in both adaptive and innate immunity. The aim of the present study was to assess the association of TLR5-rs5744168, TLR9-rs187084, and TLR9-rs352140 single nucleotide polymorphisms (SNPs) with susceptibility to systemic lupus erythematosus (SL...

Full description

Bibliographic Details
Main Authors: Ola Mohammad Gharbia, Sherine Abdel Rahman Bassiouni, Maysaa El Sayed Zaki, Shimaa Mohsen El-Beah, Manal Mohamed El-Desoky, Eman Adel Elmansoury, Mostafa Abdelsalam
Format: Article
Language:English
Published: SpringerOpen 2021-12-01
Series:Egyptian Rheumatology and Rehabilitation
Subjects:
Online Access:https://doi.org/10.1186/s43166-021-00093-y
_version_ 1818701404420702208
author Ola Mohammad Gharbia
Sherine Abdel Rahman Bassiouni
Maysaa El Sayed Zaki
Shimaa Mohsen El-Beah
Manal Mohamed El-Desoky
Eman Adel Elmansoury
Mostafa Abdelsalam
author_facet Ola Mohammad Gharbia
Sherine Abdel Rahman Bassiouni
Maysaa El Sayed Zaki
Shimaa Mohsen El-Beah
Manal Mohamed El-Desoky
Eman Adel Elmansoury
Mostafa Abdelsalam
author_sort Ola Mohammad Gharbia
collection DOAJ
description Abstract Background Toll-like (TLRs) play a crucial role in both adaptive and innate immunity. The aim of the present study was to assess the association of TLR5-rs5744168, TLR9-rs187084, and TLR9-rs352140 single nucleotide polymorphisms (SNPs) with susceptibility to systemic lupus erythematosus (SLE) and lupus nephritis (LN) in Egyptian patients. Results The C allele and homozygous CC genotype of the TLR9-rs352140 in co-dominant and recessive models were more prevalent in SLE patients than controls (P = 0.047, P = 0.017, and P = 0.005 respectively). In contrast, allelic and genotyping distribution of TLR5-rs5744168 and TLR9-rs187084 SNPs showed no association with the risk of SLE. The T allele of the TLR5-rs5744168 was more prevalent in LN patients than controls (P = 0.021). The homozygous TT genotype of TLR5-rs5744168 SNP was more prevalent in LN patients in the co-dominant and the recessive models than controls (P = 0.036 and P = 0.011 respectively). The C allele of the TLR9-rs352140 was more prevalent in LN patients than controls (P = 0.015). The homozygous CC genotype of the TLR9-rs352140 SNP was more prevalent in LN than controls in co-dominant and recessive models (P = 0.002 and P < 0.001). In the recessive model of the TLR5-rs5744168 SNP, the TT genotype was found in 3.2% of the SLE patients while none of the SLE patients without LN or controls had TT genotype (P = 0.036). Also, in the recessive model of the TLR9-rs352140 SNP, the CC genotype was significantly more frequent in SLE patients with LN than without LN (44.4% vs 29.9%, P = 0.045). Conclusion Our results support the potential role of TLR5-rs5744168 SNP and TLR9-rs3532140 SNP not only in increasing the risk for development of SLE, but also in increasing the risk of LN in SLE patients among the Egyptian population.
first_indexed 2024-12-17T15:20:18Z
format Article
id doaj.art-3d9114f05c3d4209a4fab8df09a87347
institution Directory Open Access Journal
issn 1110-161X
2090-3235
language English
last_indexed 2024-12-17T15:20:18Z
publishDate 2021-12-01
publisher SpringerOpen
record_format Article
series Egyptian Rheumatology and Rehabilitation
spelling doaj.art-3d9114f05c3d4209a4fab8df09a873472022-12-21T21:43:24ZengSpringerOpenEgyptian Rheumatology and Rehabilitation1110-161X2090-32352021-12-0148111010.1186/s43166-021-00093-yToll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patientsOla Mohammad Gharbia0Sherine Abdel Rahman Bassiouni1Maysaa El Sayed Zaki2Shimaa Mohsen El-Beah3Manal Mohamed El-Desoky4Eman Adel Elmansoury5Mostafa Abdelsalam6Physical Medicine, Rheumatology and Rehabilitation Department, Faculty of Medicine, Mansoura UniversityPhysical Medicine, Rheumatology and Rehabilitation Department, Faculty of Medicine, Mansoura UniversityClinical Pathology Department, Faculty of Medicine, Mansoura UniversityMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Mansoura UniversityMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Mansoura UniversityMedical Microbiology and Immunology Department, Faculty of Medicine, Mansoura UniversityMansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura UniversityAbstract Background Toll-like (TLRs) play a crucial role in both adaptive and innate immunity. The aim of the present study was to assess the association of TLR5-rs5744168, TLR9-rs187084, and TLR9-rs352140 single nucleotide polymorphisms (SNPs) with susceptibility to systemic lupus erythematosus (SLE) and lupus nephritis (LN) in Egyptian patients. Results The C allele and homozygous CC genotype of the TLR9-rs352140 in co-dominant and recessive models were more prevalent in SLE patients than controls (P = 0.047, P = 0.017, and P = 0.005 respectively). In contrast, allelic and genotyping distribution of TLR5-rs5744168 and TLR9-rs187084 SNPs showed no association with the risk of SLE. The T allele of the TLR5-rs5744168 was more prevalent in LN patients than controls (P = 0.021). The homozygous TT genotype of TLR5-rs5744168 SNP was more prevalent in LN patients in the co-dominant and the recessive models than controls (P = 0.036 and P = 0.011 respectively). The C allele of the TLR9-rs352140 was more prevalent in LN patients than controls (P = 0.015). The homozygous CC genotype of the TLR9-rs352140 SNP was more prevalent in LN than controls in co-dominant and recessive models (P = 0.002 and P < 0.001). In the recessive model of the TLR5-rs5744168 SNP, the TT genotype was found in 3.2% of the SLE patients while none of the SLE patients without LN or controls had TT genotype (P = 0.036). Also, in the recessive model of the TLR9-rs352140 SNP, the CC genotype was significantly more frequent in SLE patients with LN than without LN (44.4% vs 29.9%, P = 0.045). Conclusion Our results support the potential role of TLR5-rs5744168 SNP and TLR9-rs3532140 SNP not only in increasing the risk for development of SLE, but also in increasing the risk of LN in SLE patients among the Egyptian population.https://doi.org/10.1186/s43166-021-00093-yToll-like receptorSystemic lupus erythematosusLupus nephritisSingle nucleotide polymorphisms
spellingShingle Ola Mohammad Gharbia
Sherine Abdel Rahman Bassiouni
Maysaa El Sayed Zaki
Shimaa Mohsen El-Beah
Manal Mohamed El-Desoky
Eman Adel Elmansoury
Mostafa Abdelsalam
Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients
Egyptian Rheumatology and Rehabilitation
Toll-like receptor
Systemic lupus erythematosus
Lupus nephritis
Single nucleotide polymorphisms
title Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients
title_full Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients
title_fullStr Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients
title_full_unstemmed Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients
title_short Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients
title_sort toll like receptor 5 and toll like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in egyptian patients
topic Toll-like receptor
Systemic lupus erythematosus
Lupus nephritis
Single nucleotide polymorphisms
url https://doi.org/10.1186/s43166-021-00093-y
work_keys_str_mv AT olamohammadgharbia tolllikereceptor5andtolllikereceptor9singlenucleotidepolymorphismsandriskofsystemiclupuserythematosusandnephritisinegyptianpatients
AT sherineabdelrahmanbassiouni tolllikereceptor5andtolllikereceptor9singlenucleotidepolymorphismsandriskofsystemiclupuserythematosusandnephritisinegyptianpatients
AT maysaaelsayedzaki tolllikereceptor5andtolllikereceptor9singlenucleotidepolymorphismsandriskofsystemiclupuserythematosusandnephritisinegyptianpatients
AT shimaamohsenelbeah tolllikereceptor5andtolllikereceptor9singlenucleotidepolymorphismsandriskofsystemiclupuserythematosusandnephritisinegyptianpatients
AT manalmohamedeldesoky tolllikereceptor5andtolllikereceptor9singlenucleotidepolymorphismsandriskofsystemiclupuserythematosusandnephritisinegyptianpatients
AT emanadelelmansoury tolllikereceptor5andtolllikereceptor9singlenucleotidepolymorphismsandriskofsystemiclupuserythematosusandnephritisinegyptianpatients
AT mostafaabdelsalam tolllikereceptor5andtolllikereceptor9singlenucleotidepolymorphismsandriskofsystemiclupuserythematosusandnephritisinegyptianpatients